Showing 8,441 - 8,460 results of 61,189 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 50 ((mean decrease) OR (a decrease)) ))', query time: 1.19s Refine Results
  1. 8441
  2. 8442

    Image_5_CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment.TIF by Yinjiang Zhang (5030006)

    Published 2021
    “…Also, hsa-miR-4278 and hsa-miR-324-5p, two potential miRNA targets of CLEC4s, were uncovered. …”
  3. 8443

    Comparison of the amount of locomotor activity (mean counts per day) and the night-day ratio in control and diabetic animals submitted to two light schedules. by Hasna Lahouaoui (595100)

    Published 2014
    “…(B) In the second light schedule, animals were submitted to successive decreases in light intensity. These SZT-diabetic mice exhibited a reduction in their total locomotor activity at the three light intensities (at 1000 lux: controls: 2099.5±122.1 counts; STZ-diabetic: 1704.7±125.9 counts; p≤0.01; at 300 lux: controls: 2658.7±112.9 counts; STZ-diabetic: 2124.4±0.1 counts; p≤0.001 and at 100 lux: controls: 2864.7±58.4 counts; STZ-diabetic: 2508.7±47.5 counts; p≤0.05), with a significant decreased ratio of night-day activity at 300 lux and 100 lux. …”
  4. 8444

    S1 Data - by Jia Long (288557)

    Published 2024
    “…The total chlorophyll content of blueberry leaves at 25% light intensity increased by 76.4% compared with CK during the blue fruiting stage; the maximum net photosynthetic rate (Pmax), light compensation point (LCP), light saturation point (LSP), rate of dark respirations (Rd), inter-cellular CO<sub>2</sub> concentration (Ci), stomatal conductance (Gs), transpiration rate (Tr), net photosynthesis rate (Pn), and chlorophyll a/b showed a decreasing trend with decreasing light intensity. …”
  5. 8445
  6. 8446
  7. 8447

    The effects of purmorphamine and Msi1 knockdown on miR-148a and miR-148b expression. by In-Sun Hong (284033)

    Published 2013
    “…The expression levels of miR-148a (<b>A</b>) and miR-148b (<b>B</b>) were decreased by purmorphamine treatment. …”
  8. 8448

    Potential binding regions mapped onto the crystal structure of AIMP3. by Yeqing Tao (4348336)

    Published 2017
    “…<p>Upper left: Interface I in yellow, including residues Arg<sup>50</sup>, Thr<sup>68</sup>, Lys<sup>75</sup>, Ala<sup>91</sup>, Gln<sup>94</sup>, Gln<sup>95</sup>, Glu<sup>98</sup>, and Asp<sup>119</sup>. …”
  9. 8449
  10. 8450
  11. 8451
  12. 8452

    Table1_Plasmalogen Loss in Sepsis and SARS-CoV-2 Infection.DOCX by Daniel P. Pike (12791573)

    Published 2022
    “…Additionally total plasmenylcholine levels were decreased in the plasma of SARS-CoV-2 infected mice. …”
  13. 8453

    Table1_Plasmalogen Loss in Sepsis and SARS-CoV-2 Infection.DOCX by Daniel P. Pike (12791573)

    Published 2022
    “…Additionally total plasmenylcholine levels were decreased in the plasma of SARS-CoV-2 infected mice. …”
  14. 8454

    Table1_Plasmalogen Loss in Sepsis and SARS-CoV-2 Infection.DOCX by Daniel P. Pike (12791573)

    Published 2022
    “…Additionally total plasmenylcholine levels were decreased in the plasma of SARS-CoV-2 infected mice. …”
  15. 8455
  16. 8456
  17. 8457

    Discovery of β‑Arrestin Biased Ligands of 5‑HT<sub>7</sub>R by Youngjae Kim (1463614)

    Published 2018
    “…In order to identify 5-HT<sub>7</sub>R ligands with biased agonism, we designed and synthesized a series of tetrahydroazepine derivatives <b>1</b> and <b>2</b> with arylpyrazolo moiety or arylisoxazolo moiety. …”
  18. 8458

    Differential Regulation of Integrin α5 and β4 in Normal and Psoriatic Epidermal Keratinocytes by Jiong Zhou (801670)

    Published 2022
    “…Psoriatic keratinocytes’ α5 was increased by IL-13/17A, decreased by IFN-γ; but β4 increased by IL-17A, IFN-γ. …”
  19. 8459

    Discovery of β‑Arrestin Biased Ligands of 5‑HT<sub>7</sub>R by Youngjae Kim (1463614)

    Published 2018
    “…In order to identify 5-HT<sub>7</sub>R ligands with biased agonism, we designed and synthesized a series of tetrahydroazepine derivatives <b>1</b> and <b>2</b> with arylpyrazolo moiety or arylisoxazolo moiety. …”
  20. 8460